Retirement Planning Company of New England’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Sell
1,720
-52
-3% -$8.94K 0.12% 188
2026
Q1
$299K Sell
1,772
-2
-0.1% -$342 0.12% 196
2025
Q4
$299K Sell
1,774
-12
-0.7% -$1.95K 0.12% 190
2025
Q3
$258K Sell
1,786
-3
-0.2% -$409 0.1% 207
2025
Q2
$226K Sell
1,789
-11
-0.6% -$1.35K 0.1% 214
2025
Q1
$230K Sell
1,800
-25
-1% -$3.39K 0.11% 203
2024
Q4
$241K Sell
1,825
-6
-0.3% -$843 0.12% 198
2024
Q3
$267K Sell
1,831
-71
-4% -$10.3K 0.13% 183
2024
Q2
$261K Buy
1,902
+6
+0.3% +$801 0.14% 175
2024
Q1
$260K Sell
1,896
-68
-3% -$9.29K 0.14% 183
2023
Q4
$267K Sell
1,964
-49
-2% -$5.98K 0.12% 180
2023
Q3
$246K Sell
2,013
-526
-21% -$66.9K 0.14% 159
2023
Q2
$322K Sell
2,539
-31
-1% -$4.03K 0.19% 149
2023
Q1
$332K Sell
2,570
-52
-2% -$6.81K 0.2% 148
2022
Q4
$344K Sell
2,622
-29
-1% -$3.75K 0.22% 131
2022
Q3
$310K Sell
2,651
-56
-2% -$6.95K 0.22% 136
2022
Q2
$318K Sell
2,707
-75
-3% -$8.9K 0.22% 139
2022
Q1
$362K Buy
2,782
+11
+0.4% +$1.43K 0.2% 139
2021
Q4
$422K Buy
+2,771
New +$429K 0.21% 133

Other funds holding IBB

Retirement Planning Company of New England's IBB Position: Q2 2026 in Review

Retirement Planning Company of New England reduced its iShares Biotechnology ETF (IBB) stake by 2.9% in Q2 2026, selling an estimated $8.94K and leaving 1,720 shares worth $327K. The position accounts for 0.12% of the portfolio, ranked #188.

Retirement Planning Company of New England first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $422K in Q4 2021. 650 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Retirement Planning Company of New England held 1,720 shares of iShares Biotechnology ETF worth $327K as of Q2 2026.
  • Retirement Planning Company of New England sold 52 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.94K.
  • iShares Biotechnology ETF made up 0.12% of Retirement Planning Company of New England's portfolio in Q2 2026, its #188 holding.
  • Retirement Planning Company of New England first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • Retirement Planning Company of New England's iShares Biotechnology ETF position peaked at $422K in Q4 2021.
  • 650 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.